We are delighted to share with you some of our recent press which highlights our partnerships and impact over the past several months.
We are honored to have been interviewed and profiled by the Advisory Board in their Daily Briefing which reaches over 200k health care industry subscribers. We hope this will inform health care leaders are looking for ways to advance health equity in their organizations.
Expanding on the provision of over 4,000 meals to vaccine recipients in LA, Stop the Spread's "Vaccine+" program paired LA-based Bento with Community Healthcare Network of New York to use vaccine appointments to provide best practice nutrition/diabetes care.
We continue to seek additional avenues through which to share our experience, champion our partners, and promote our Playbook for Community-based Vaccinations through which we have made the tools we have developed available for free in perpetuity thanks to GitBook.
Thank you for your continued, active support of our mission and work.
About ImpactAssets ImpactAssets is a nonprofit financial services firm that increases the flow of capital into investments delivering financial, social and environmental returns. The ImpactAssets Donor Advised Fund and field-building initiatives enable philanthropists, other asset owners and their wealth advisors to advance social or environmental change through investment and granting.
About Stop the Spread Stop the Spread fosters the private sector’s response to COVID-19. STS addresses the evolving critical needs of the pandemic by identifying and vetting novel solutions and providing innovators with capacity building support including access to impact investment and philanthropic capital through ImpactAssets’ COVID Response Funds. Through research, partnerships and coalition building, STS serves the communities hit hardest by COVID-19 with a focus on addressing the needs of historically underserved populations. STS’ partner network totals over 650 companies and organizations and has resulted in more than 300 value-added connections that have spurred the production of more than 40,000 ventilators and 20 million units of PPE, supported development of novel diagnostics and therapeutics, and promoted equitable allocation of resources.
LEGAL AND PROGRAM DISCLAIMER: This is not a solicitation to buy or sell securities, nor a private placement offering pursuant to any private placement memorandum that must be issued to qualified investors. It is an informational description of charitably oriented, social purpose investment options that have been approved by ImpactAssets. It is only for use by its donors. There is no guarantee of any recovery of capital.